To elucidate the clinical value of SLITs and their impact on the prognosis of patients with NSCLC, an analysis of the effect of SLITs (SLIT1–3) on overall survival was carried out in 531 NSCLC patients derived from The Cancer Genome Atlas (TCGA) database. This evidence concerns the gene SLIT1 and non-small cell lung carcinoma.